Zobrazeno 1 - 8
of 8
pro vyhledávání: '"O. Yu. Novikova"'
Autor:
M. Yu. Fedyanin, L. Yu. Vladimirova, V. A. Chubenko, L. A. Zagorskaya, A. V. Belyaeva, O. L. Fakhrutdinova, S. A. Belukhin, A. S. Zhabina, L. V. Khalikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, G. Z. Mukhametshina, A. I. Khasanova, A. V. Belonogov, Kh. S. Musaeva, O. Yu. Novikova, I. Yu. Stradaeva, I. L. Popova, S. P. Erdniev, A. K. Ivanova, A. V. Androsova, P. S. Feoktistova, E. S. Kuzmina, E. V. Karabina, O. V. Nekrasova, O. V. Sekhina, A. A. Mishchenko, L. A. Mukova, B. Kh. Kertiev, G. I. Kosar, S. N. Osodoeva, A. I. Kats, R. R. Malina, M. A. Lyadova, A. A. Tryakin, S. A. Tyulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 11, Iss 3-4, Pp 11-17 (2022)
Objective: to compare the efficacy and toxicity of aflibercept and bevacizumab in combination with fOLfIRI in secondline therapy for patients with metastatic colon cancer.Materials and methods. we performed a retrospective analysis of data on patient
Externí odkaz:
https://doaj.org/article/2d03f1018a45430f833cbda769ac5776
Autor:
M. Yu. Fedyanin, F. V. Moiseenko, M. A. Lyadova, V. N. Vorobyeva, V. V. Petkau, A. V. Fateeva, E. S. Kuzmina, O. Yu. Novikova, V. A. Chubenko, N. Kh. Abduloeva, A. A. Kudryavtsev, E. O. Ignatova, R. R. Shakirov, O. A. Pardabekova, L. V. Kindyalova, S. P. Pelikh, O. A. Gladkov, S. A. Tjulandin, A. A. Tryakin
Publikováno v:
Тазовая хирургия и онкология, Vol 11, Iss 1, Pp 11-20 (2021)
Objective: to compare the efficacy and tolerability of second‑line chemotherapy with original bevacizumab (Avastin) and biosimilar bevacizumab produced by “Biocad” (Avegra) in patients with metastatic colon cancer.Materials and methods. This re
Externí odkaz:
https://doaj.org/article/ab81d2b18b6d483387d0ba158a69a3b1
Autor:
M. Yu. Fedyanin, L. Yu. Vladimirova, V. A. Chubenko, L. A. Zagorskaya, A. V. Belyaeva, L. V. Bolotina, F. V. Moiseenko, O. L. Fakhrutdinova, S. A. Belukhin, A. S. Zhabina, L. V. Khalikova, V. M. Moiseenko, А. А. Meshcheryakov, E. V. Artamonova, I. A. Pokataev, A. I. Khasanova, A. V. Belonogov, Kh. S. Musaeva, O. Yu. Novikova, I. Yu. Stradaeva, I. L. Popova, G. Z. Mukhametshina, R. V. Orlova, S. P. Erdniev, A. K. Ivanova, A. V. Androsova, P. S. Feoktistova, E. S. Kuzmina, E. V. Karabina, O. V. Nekrasova, V. M. Sherstnev, A. A. Mishchenko, L. A. Mukova, B. Kh. Kertiev, G. I. Kosar, S. N. Osodoeva, A. I. Kats, R. R. Malina, A. A. Tryakin, S. A. Tjulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 9, Iss 2, Pp 29-37 (2019)
Objective: to identify factors associated with efficacy of an aflibercept-chemotherapy combination in patients with metastatic colon cancer.Materials and methods. This retrospective multicenter study was conducted in 20 clinics from 15 regions of the
Externí odkaz:
https://doaj.org/article/743bdd161bd0481991ada713bfba7dbc
Autor:
Mikhail Mazhbich, L. Yu. Vladimirova, O. Yu. Novikova, Vladislav Petkau, Galina Alekseeva, M. A. Mukhina, Ilya Tsimafeyeu, Andrey Semenov, Ruslan Zukov, Galina Statsenko, Ludmila Gurina, Irina L. Popova, I. V. Zaytsev
Publikováno v:
Onkourologiâ, Vol 17, Iss 3, Pp 102-109 (2021)
Background. Data on the overall survival (OS) of patients with metastatic bladder cancer (BCa) is rarely published.The objective of the URRU register study is to assess OS and collect information on the administration of different treatments in patie
Autor:
O. Yu. Novikova, T. P. Bondarenko
Publikováno v:
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 5:185-191
Autor:
M. Yu. Fedyanin, L. A. Zagorskaya, O. L. Fakhrutdinova, O. V. Nekrasova, S. A. Belukhin, A. A. Mishchenko, L. Yu. Vladimirova, Alfia Khasanova, B. Kh. Kertiev, Ye. V. Karabina, A. K. Ivanova, A. V. Belyayeva, Viacheslav Chubenko, A. V. Androsova, Alexey Tryakin, P S Feoktistova, Rashida Orlova, Guzel Mukhametshina, S. N. Osodoyeva, R. R. Malina, I. A. Pokatayev, O. Yu. Novikova, L. V. Khalikova, V. M. Sherstnev, A. A. Meshcheryakov, Sanal Erdniev, Elena Artamonova, Kh. S. Musayeva, Irina L. Popova, L. A. Mukova, Larisa Bolotina, F. V. Moiseyenko, A. I. Katz, Ye. S. Kuzmina, G. I. Kosar, I. Yu. Stradayeva, Vladimir Moiseyenko, S. A. Tyulyandin, A S Zhabina, A. Belonogov
Publikováno v:
Malignant tumours. 9:53-63
Purpose. To assess the incidence and severity of adverse events; to explore clinical factors associated with grade 3–4 non-hematologic toxicity; to assess the immediate efficacy and progression-free survival during treatment with the FOLFIRI regime
Autor:
T. P. Bondarenko, O. Yu. Novikova
Publikováno v:
Bulletin of Problems Biology and Medicine. 3:54
Publikováno v:
2016 IEEE NW Russia Young Researchers in Electrical and Electronic Engineering Conference (EIConRusNW).
The paper is devoted to the development and quality assessment of lightweight pseudo-random number generators (PNRG). The design principles of lightweight PRNG (LW-PNRG) are described. The requirements for LW-PNRG quality are formulated. This paper g